⌘K

Home/Insiders/Mahatme Ujwala

MU

SEC Insider//CIK 0001823894

Mahatme Ujwala

CIK 00018238941 companyMENLO PARK, CA

Transactions

2

Companies

1

Filings

1

CIK

0001823894

Recent Transactions

2 trades

Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2024-01-02$1.32/sh+52,575→ 87,575 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2024-01-02+35,000→ 35,000 total

Companies

1

Summit Therapeutics Inc.
Director
$SMMT

Recent Filings

1

4
Mahatme Ujwala
Jan 4, 2024

Address

C/O SUMMIT THERAPEUTICS INC. 2882 SAND HILL ROAD, SUITE 106

MENLO PARK, CA, 94025

View on SEC.gov